Filing Details
- Accession Number:
- 0000899243-17-018008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-06 18:14:31
- Reporting Period:
- 2017-07-05
- Filing Date:
- 2017-07-06
- Accepted Time:
- 2017-07-06 18:14:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1420565 | Aileron Therapeutics Inc | ALRN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1315797 | A Muneer Satter | C/O Aileron Therapeutics, Inc. 281 Albany Street Cambridge MA 02139 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-07-05 | 144,773 | $0.00 | 144,773 | No | 4 | C | Indirect | See footnote |
| Common Stock | Acquisiton | 2017-07-05 | 33,333 | $15.00 | 178,106 | No | 4 | P | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series D Preferred Stock | Disposition | 2017-07-05 | 847,721 | $0.00 | 85,309 | $0.00 |
| Common Stock | Series E-2 Preferred Stock | Disposition | 2017-07-05 | 183,944 | $0.00 | 18,511 | $0.00 |
| Common Stock | Series E-3 Preferred Stock | Disposition | 2017-07-05 | 159,548 | $0.00 | 16,055 | $0.00 |
| Common Stock | Series F Preferred Stock | Disposition | 2017-07-05 | 247,398 | $0.00 | 24,896 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- These shares are held by the Muneer A. Satter Revocable Trust and various other trusts and entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive power over all such shares.
Billionaire Hedge Funds
